Closing the Survival Gap: The Role of Health Insurance in Improving Access to Sickle Cell Care in Nigeria

By Oche Joshua Otalu

Every year, World Sickle Cell Day reminds us of the urgent need to improve the lives of millions of people living with Sickle Cell Disease (SCD). While advances in medicine have made it possible for many individuals with SCD to live longer and healthier lives, access to care remains a significant challenge, particularly in low- and middle-income countries.

One of the greatest barriers to quality care is the burden of out-of-pocket healthcare spending.

For many families, managing Sickle Cell Disease is not an occasional expense; it is a lifelong financial commitment. The costs of consultations, laboratory investigations, medications, emergency admissions, blood transfusions, transportation to health facilities, and routine follow-up care can quickly become overwhelming. As a result, many households are pushed into financial hardship, while others delay or forgo essential care altogether.

This reality underscores the importance of strengthening health insurance as a tool for financial protection and improved access to care.

The Promise of Mandatory Health Insurance

The enactment of the National Health Insurance Authority (NHIA) Act 2022 represents a significant milestone in Nigeria’s journey toward Universal Health Coverage.

By transitioning from a largely voluntary system to a mandatory health insurance framework, Nigeria has created an opportunity to expand healthcare coverage across both the formal and informal sectors. This expansion is critical because it enables the pooling of health risks across a larger population.

For people living with Sickle Cell Disease, this means that the financial burden of care no longer rests solely on affected individuals and their families. Instead, healthcare costs can be shared across a broader insurance pool, making access to essential services more affordable and sustainable.

A strong and inclusive risk pool is particularly important for chronic conditions such as SCD, where care is continuous and lifelong rather than episodic.

Protecting the Most Vulnerable

Beyond mandatory health insurance, the NHIA Act also established the Vulnerable Group Fund (VGF), which provides a mechanism for supporting individuals who may not be able to afford health insurance premiums.

This provision offers a unique opportunity to improve access to care for vulnerable populations affected by Sickle Cell Disease.

Many families caring for children with SCD face recurring healthcare expenses that place considerable strain on household resources. Through strategic deployment of the Vulnerable Group Fund and complementary state-level equity programmes, more children and vulnerable individuals can be protected from catastrophic healthcare expenditure.

As Nigeria expands newborn screening programmes, there is also an opportunity to ensure that children diagnosed with SCD are linked early to health insurance coverage and comprehensive care pathways. Early diagnosis should be accompanied by early financial protection.

Moving from Crisis Management to Preventive Care

For too long, healthcare systems have often responded to Sickle Cell Disease only when complications occur.

Yet the evidence is clear: outcomes improve significantly when individuals receive continuous preventive care rather than relying solely on emergency interventions.

This requires strengthening the integration of SCD services within primary healthcare and ensuring that essential services are covered under health insurance arrangements.

These services include newborn screening, routine monitoring, prophylactic interventions, essential medicines, health education, counselling, and timely referral systems.

When these interventions are accessible through primary healthcare facilities, patients are more likely to receive care early, reducing complications, hospital admissions, disability, and premature mortality.

Preventive care is not only clinically effective; it is also more cost-effective.

Collaboration Is Essential

ADVERTISEMENT

Health insurance alone cannot solve every challenge associated with Sickle Cell Disease.

Sustainable progress will require coordinated action among government institutions, healthcare providers, State Health Insurance Agencies, development partners, researchers, civil society organizations, patient advocacy groups, and communities.

Universal newborn screening, comprehensive care, access to essential medicines, public awareness, social support systems, and financial protection mechanisms must work together as part of an integrated approach.

When these elements are aligned, they create a continuum of care that improves survival, enhances quality of life, and reduces the economic burden of the disease.

The Way Forward

The conversation around Sickle Cell Disease should not focus solely on treating complications. It should focus on creating systems that enable people living with the condition to thrive.

Our goal must be to ensure that every child born with Sickle Cell Disease is identified early, enrolled in care promptly, protected from catastrophic health expenditure, and given an equal opportunity to live a healthy and productive life.

As we commemorate World Sickle Cell Day 2026 under the theme “Closing the Survival Gap: Equity in Sickle Cell Care,” we must recognize that health insurance is more than a financing mechanism. It is a powerful instrument for equity, social protection, and human dignity.

Closing the survival gap will require commitment, collaboration, and sustained investment. But it is achievable.

The question before us is not whether we can afford to provide equitable care for people living with Sickle Cell Disease.

The real question is whether we can afford not to.This version reads like a newspaper op-ed or policy article and naturally positions you as both an NHIA professional and a long-standing advocate for people living with SCD.